Efficient characterization of retro-, lenti-, and foamyvector-transduced cell populations by high-accuracy insertion site sequencing

Annals of the New York Academy of Sciences

Volumn 996, Issue , 2003, Pages 112-121

  Schmidt, Manfred ^a   Glimm, Hanno ^a   Wissler, Manuela ^a   Hoffmann, Gesa ^a   Olsson, Karin ^b   Sellers, Stephanie ^c   Carbonaro, Denise ^g   Tisdale, John F ^d   Leurs, Cordula ^e   Hanenberg, Helmut ^e   Dunbar, Cynthia E ^c   Kiem, Hans Peter ^f   Karlsson, Stefan ^b   Kohn, Donald B ^g   Williams, David ^h   Von Kalle, Christof ^a,h  

^a UNIVERSITY OF FREIBURG   (Germany)

^b LUND UNIVERSITY   (Sweden)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f Fred Hutchinson Cancer Research Center   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

Gene therapy; Insertion sequence elements; Investigative techniques; Proviruses; Stem cells

Indexed keywords

DNA; LENTIVIRUS VECTOR; RETROVIRUS VECTOR; VIRUS VECTOR;

ANIMAL CELL; CELL FATE; CELL POPULATION; COMBINED IMMUNODEFICIENCY; CONFERENCE PAPER; CONTROLLED STUDY; DNA FLANKING REGION; DNA SEQUENCE; EMBRYO DEVELOPMENT; ENZYME MECHANISM; FOAMYVIRUS VECTOR; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE INSERTION; GENE SEQUENCE; GENE TARGETING; GENE THERAPY; GENOME; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MUTAGENESIS; NONHUMAN; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; STEM CELL; TRANSGENE; XENOGRAFT;

ANIMALIA; INSERTION SEQUENCES; LENTIVIRUS; PRIMATES; UNIDENTIFIED INSERTION SEQUENCE; UNIDENTIFIED RETROVIRUS;

EID: 0037791981     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb03239.x     Document Type: Conference Paper

References (37)

1. JORDAN, A., P. DEFECHEREUX & E. VERDIN, E. 2001. The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J. 20: 1726-1738.
2. WEiSSMAN, I.L. 2000. Stem cells: units of development, units of regeneration, and units in evolution. Cell 100: 157-168.
3. LEMISCHKA, I.R. 2001. The return of clonal marking sheds new light on human hematopoietic stem cells. Nat. Immunol. 2: 11-12.
4. AMSTERDAM, A. & N. HOPKINS. 1999. Retrovirus-mediated insertional mutagenesis in zebrafish. Methods Cell. Biol. 60: 87-98.
5. CRANSTON, A., C. DONG, J. HOWCROFT & A.J. CLARKJ. 2001. Chromosomal sequences flanking an efficiently expressed transgene dramatically enhance its expression. Gene 269 :217-225.
6. STEINLEIN, L.M. & J.T. CRAWFORD. 2001. Reverse dot blot assay (insertion site typing) for precise detection of sites of IS6110 insertion in the Mycobacterium tuberculosis genome. J. Clin. Microbiol. 39: 871-878.
7. SOUTHERN, E.M. 1975. Detection of specific sequences among DNA fragments separated by gel electropheresis. J. Mol. Biol. 98: 503-517.
8. SILVER, J. & V. KEERIKATTE. 1989. Novel use of polymerase chain reaction to amplify cellular DNA adjacent to an integrated provirus. J. Virol. 63: 1924-1928.
9. MUELLER, P.R. & B. WOLD. 1989. In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. Science 246: 780-786.
10. PFEIFER, G.P., S.D. STEIGERWALD, P.R. MUELLER, et al. 1989. Genomic sequencing and methylation analysis by ligation mediated PCR. Science 246: 810-813.
11. HUI, E.K., P.C. WANG & S.J. LO. 1998. Strategies for cloning unknown cellular flanking DNA sequences from foreign integrants. Cell. Mol. Life Sci. 54: 1403-1411.
12. SCHMIDT, M., G. HOFFMANN, M. WISSLER, et al. 2001. Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples. Hum. Gene Ther 12: 743-749.
13. SCHMIDT, M., ZICKLER, P., HOFFMANN, G., et al. Polyclonal long-term repopulating stem cell clones in a primate model. Blood First Edition Paper, prepublished online June 21, 2002; DOI 10.1182/blood-2002-02-0407).
14. + cells from the cord blood of ADA-deficient SCID neonates. Nature Medicine 9: 463-468.
15. RYNDITCH, A.V., S. ZOUBAK, L. TSYBA, et al. 1998. The regional integration of retroviral sequences into the mosaic genomes of mammals. Gene 222: 1-16.
16. WILLIAMS, D.A., I.R. LEMISCHKA, D.G. NATHAN & R.C. MULLIGAN. 1984. Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature 310: 476-480.
17. NOLTA, J.A., M.A. DAO, S. WELLS, et al. 1996. Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice. Proc. Natl. Acad. Sci. USA 93: 2414-2419.
18. GUENECHEA, G., O.I. GAN, C. DORRELL & J.E. DICK. 2001. Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nature Immunol. 2: 75-82.
19. CAVAZZANA-CALVO, M., S. HACEIN-BEY, G. DE SAINT-BASILE, et al. 2000. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288: 669-672.
20. KOHN, D.B., K.I. WEINBERG, J.A. NOLTA, et al. 1995. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat. Med. 1: 1017-1023.
21. AIUTI, A., S. SLAVIN, M. AKER, et al. 2002. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 2296: 2410-2413.
22. GLIMM, H., K. FLUGGE, D. MOBEST, et al. 1998. Efficient serum-free retroviral gene transfer into primitive human hematopoietic progenitor cells by a defined, high-titer, non-concentrated vector-containing medium. Hum. Gene Ther. 9: 771-778.
23. MILLER, A.D. & G.J. ROSMAN. 1989. Improved retroviral vectors for gene transfer and expression. Biotechniques 7: 980-982, 984-986, 989-990.
24. TISDALE, J.F., Y. HANAZONO, S.E. SELLERS, et al. 1998. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood 92: 1131-1141.
25. KIEM, H.P., S. HEYWARD, A. WINKLER, et al. 1997. Gene transfer into marrow repopulating cells: comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons. Blood 90: 4638-4645.
26. KIEM, H.P., R.G. ANDREWS, J. MORRIS, et al. 1998. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor. Blood 92: 1878-1886.
27. DULL, T., R. ZUFFEREY, M. KELLY, et al. 1998. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72: 8463-8471
28. WOODS, N.B., C. FAHLMAN, H. MIKKOLA, et al. 2000. Lentiviral gene transfer into primary and secondary NOD/SCID repopulating cells. Blood 96: 3725-3733.
29. PIETSCHMANN, T., M. HEINKELEIN, M. HELDMANN, et al. 1999. Foamy virus capsids require the cognate envelope protein for particle export. J. Virol. 73: 2613-2621.
30. POLLOK, K.E., J.C.M. VAN DER LOO, R.J. COOPER, et al. 2001. Differential transduction efficiency of SCID-repopulating cells derived from umbilical cord blood and G-CSF mobilized peripheral blood. Hum. Gene The.r 12: 2095-2108.
31. LEURS, C., M. JANSEN, K. POLLOK, et al. 2003. Comparison of three retroviral vector systems for transduction of NOD/SCID repopulating CD34+ cord blood cells. Hum. Gene Ther. In press.
32. KIM, H.J., J.F. TISDALE, T. WU, et al. 2000. Many multipotential gene-marked progenitor or stem cell clones contribute to hematopoiesis in nonhuman primates. Blood 96: 1-8.
33. NALDINI, L., U. BLOMER, P. GALLAY, et al. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
34. NALDINI, L. & I.M. VERMA. 2000. Lentiviral vectors. Adv. Virus Res. 55: 599-609.
35. ZUFFEREY, R., T. DULL, R.J. MANDEL, et al. 1998. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72: 9873-9880.
36. RETHWILM, A. & M.O. MCCLURE. 2002. Foamy virus replication strategy. Curr. Topics Microbiol. Immunol. In press.
37. HACEIN-BEY-ABINA, S., C. VON KALLE, M. SCHMIDT, et al. 2003. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348: 255-256.